Health: Scientists Manufacture Possible Single-Shot HIV Vaccine
For years, the way to deal with HIV has been through antiretroviral treatment, which involves having the person with HIV taking a daily regimen of medication for the rest of their lives. Attempts at a vaccine have been made over the years, but usually involve a series of shots given over the course of a year.
However, a new study published in Immunity and reported on by Plus offers the possibility of a single-shot HIV vaccine. The Scripps Research Institute in La Jolla, California, has manufactured a single-shot HIV vaccine that could possibly change the course of how we deal with HIV.
Other HIV vaccines that are being studied make the body produce normal anti-HIV antibodies that significantly lessen the chances of HIV contraction. However, the vaccine made by the Scripps researchers induces the production of bNAbs, which are usually only seen in people who have lived with HIV for many years. These antibodies are rare and potent, and researchers believe this will translate to a “complete response” to HIV should a person be exposed to the virus. Not only would the vaccine repel the virus, it would also contain any infections that occur.
It may still take years before the vaccine goes out to the market, as the research was done as a proof of concept study. From there, researchers will now test how safe and effective the vaccine is compared to other available options.
This is yet another breakthrough in the fight against HIV after scientists last year were able to successfully destroy HIV-infected cells in a laboratory setting.
What do you guys think of this new development in the fight against HIV? What other advances against HIV do you wish to see in 2019? Share your thoughts and comments with us below.